ロード中...
Minimax and admissible adaptive two-stage designs in phase II clinical trials
BACKGROUND: Simon’s two-stage design is the most widely implemented among multi-stage designs in phase II clinical trials to assess the activity of a new treatment in a single-arm study. In this two-stage design, the sample size from the second stage is fixed regardless of the number of responses ob...
保存先:
| 出版年: | BMC Med Res Methodol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4969653/ https://ncbi.nlm.nih.gov/pubmed/27485595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12874-016-0194-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|